Tag: MHRA
Samsung Bioepis reaches settlement agreement for Eylea (Aflibercept) biosimilar in Europe...
This agreement enables Samsung Bioepis to launch SB15 in the United Kingdom (UK) from January 2026, in the rest of Europe from April 2026
Glenmark bags exclusive multi-regional rights to Aumolertinib from Hansoh Pharma
Partnership strengthens Glenmark’s oncology strategy across high-potential markets
Biocon’s European partner Zentiva receives approval from UK MHRA for Liraglutide
The company had earlier announced about the approval received from the MHRA for Liraglutide
Quality enhancement takes center stage at IPA’s 8th Advanced GMP Workshop
The Workshop took place virtually on 3-4 October 2023, with 20+ subject matter experts, industry leaders and global regulators from USFDA, MHRA, CDSCO